University of MiamiHealth System

Miami, Florida 33136

11 studies enrolling now · 38 studies all time

What they study most

Advanced Cutaneous Squamous Cell Carcinoma, Advanced Synovial Sarcoma, Aneurysm, Brain, Artificial Intelligence (AI), Autoimmune Hepatitis, Basal Cell Carcinoma, Blood Vessel Injury, Breast Cancer Screening, Burn Injury, Burns, COVID-19, COVID-19 Prevention

Studies at this site

• A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines — Recruiting now
• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States — Recruiting now
• Early Detection of Vaping-related Vascular Diseases — Recruiting now
• Global Paradise System US Post Approval Study — Recruiting now
• A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms — Recruiting now
• Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC) — Recruiting now
• CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) — Recruiting now
• Stroke Thrombectomy and Aneurysm Registry — Recruiting now
• A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients — Recruiting now
• Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY — Recruiting now
• Antibiotic-coated Braided Suture Study — Starting soon
• A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy — Running, not enrolling
• PRimary Care Opioid Use Disorders Treatment (PROUD) Trial — Completed
• Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery — Paused
• A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment — Running, not enrolling
• A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) — Running, not enrolling
• The Acute Burn ResUscitation Multicenter Prospective Trial — Completed
• NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors — Running, not enrolling
• Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) — Completed
• Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa — Running, not enrolling
• Liver Cirrhosis Network Cohort Study — Running, not enrolling
• A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults — Completed
• 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide — Completed
• FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors — Stopped early
• Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer — Running, not enrolling
• Expanded Indications in the MED-EL Pediatric Cochlear Implant Population — Completed
• Noninterventional Study Evaluating Parkinson's Disease Diary Use — Running, not enrolling
• Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen — Completed
• The RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps — Completed
• mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Withdrawn before enrolling
• Rapid Detection of Staphylococcus Aureus in Burn Patients — Completed
• Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment — Completed
• A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection — Completed
• A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 — Stopped early
• Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy — Paused
• Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis — Completed
• Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children — Completed
• An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 — Completed